Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 74,"Piessevaux G, et al., Mamm Genome. 2008 Dec 4",mammary gland integrity trait,,RS:0001450,SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm,female,0 days,52,,CMO:0000344,mammary tumor growth rate,,the first 3 weeks of tumor growth,,0.73,cm/week,0.03,0.2163,MMO:0000160,unspecified method,,0,,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)",11511,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)" 73,"Stieber D, et al., Int J Cancer. 2007 Jan 17",mammary gland integrity trait,,RS:0001450,SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm,female,120 days to 99 days,46,,CMO:0000344,mammary tumor growth rate,,the first 3 weeks of tumor growth,,0.79,cm/week,0.0074,0.05,MMO:0000160,unspecified method,,0.0,,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11348,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) "